EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.64 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | -51.0% | 238,034 | +15.5% | 0.00% | -100.0% |
| Q2 2023 | $145 | -42.7% | 206,113 | -27.0% | 0.00% | 0.0% |
| Q1 2023 | $253 | -56.2% | 282,471 | -42.4% | 0.00% | -66.7% |
| Q4 2022 | $578 | -99.5% | 490,488 | +3575.4% | 0.00% | – |
| Q2 2021 | $114,000 | +165.1% | 13,345 | +360.5% | 0.00% | – |
| Q4 2019 | $43,000 | -65.0% | 2,898 | -75.0% | 0.00% | -100.0% |
| Q2 2019 | $123,000 | -44.3% | 11,602 | -26.7% | 0.00% | 0.0% |
| Q1 2019 | $221,000 | -58.7% | 15,838 | -69.9% | 0.00% | -66.7% |
| Q4 2018 | $535,000 | -49.0% | 52,642 | -39.8% | 0.00% | -25.0% |
| Q3 2018 | $1,049,000 | +52.7% | 87,427 | +55.4% | 0.00% | +33.3% |
| Q2 2018 | $687,000 | +236.8% | 56,266 | +171.2% | 0.00% | +200.0% |
| Q1 2018 | $204,000 | – | 20,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |